REPLICEL LIFE SCIENCESREPLICEL LIFE SCIENCESREPLICEL LIFE SCIENCES

REPLICEL LIFE SCIENCES

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪702.49 K‬EUR
0.0150EUR
‪−213.10 K‬EUR
‪241.81 K‬EUR
‪41.01 M‬
Beta (1Y)
1.75

About REPLICEL LIFE SCIENCES


CEO
Andrew Schutte
Headquarters
Vancouver
Founded
1967
FIGI
BBG01B09K0K9
RepliCel Life Sciences, Inc. is a regenerative medicine company, which engages in developing cell therapies for aesthetic and orthopedic conditions. Its products include RCH-01, RCS-01, RCT-01, and DermaPrecise. The company was founded by Kevin McElwee and Rolf Hoffmann on April 24, 1967 and is headquartered in Vancouver, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange REPLICEL LIFE SCIENCES stocks are traded under the ticker P6P2.
P6P2 reached its all-time high on Jan 13, 2017 with the price of 1.3690 EUR, and its all-time low was 0.0005 EUR and was reached on Oct 25, 2024. View more price dynamics on P6P2 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track REPLICEL LIFE SCIENCES financials in yearly and quarterly reports right on TradingView.
REPLICEL LIFE SCIENCES is going to release the next earnings report on May 6, 2025. Keep track of upcoming events with our Earnings Calendar.
P6P2 net income for the last quarter is ‪−143.52 K‬ EUR, while the quarter before that showed ‪−128.21 K‬ EUR of net income which accounts for −11.94% change. Track more REPLICEL LIFE SCIENCES financial stats to get the full picture.
No, P6P2 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. REPLICEL LIFE SCIENCES EBITDA is ‪−380.57 K‬ EUR, and current EBITDA margin is −391.47%. See more stats in REPLICEL LIFE SCIENCES financial statements.
Like other stocks, P6P2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REPLICEL LIFE SCIENCES stock right from TradingView charts — choose your broker and connect to your account.